Non-Interventional Post Marketing Surveillance Study of Neovasculgen® in Patients With Chronic Lower Limb Ischemia

PHASE4CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Lower Limb Ischemia
Interventions
DRUG

Neovasculgen®

Treatment according to routine clinical practice at the discretion of the treating physician. Patients receive two local intramuscular injections of Neovasculgen® at a course dose of 2.4 mg according to the summary of product characteristics (SmPC).

Trial Locations (30)

129110

"Federal State Institution GBUZ MO MONIKI Named after M.F. Vladimirskogo ", Moscow

150023

"State Institution of Health Yaroslavl Region Clinical Hospital # 10", Yaroslavl

170020

"Budgetary State Institution Regional Hospital", Tver'

192242

St. Petersburg Research Institute of Emergency Care named after I.I. Dzhanelidze, Saint Petersburg

344022

"State Educational Institution of Higher Professional Education Rostov State Medical University", Rostov-on-Don

350086

Regional Clinical Hospital #1 Named after Prof. S.V.Ochapovskogo of the Ministry of Health of Krasnodar Region, Krasnodar

394036

Voronezh State Medical Academy Named After N.N Burdenko, Voronezh

420064

"Public Health Autonomous Institution Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan", Kazan'

424037

Republican Clinical Hospital, Yoshkar-Ola

443095

"State Budgetary Healthcare Institution Samara Regional Clinical Hospital Named after M.I. Kalinin ", Samara

445023

Budgetary State Institution Samara Region Hospital # 2 Named after V.V. Banykin, Tolyatti

450071

City Clinical Hospital # 21 Ufa, Ufa

454071

"Municipal Budget Health Care Institution City Clinical Hospital № 8. Chelyabinsk", Chelyabinsk

620102

Sverdlovsk Regional Clinical Hospital #1, Yekaterinburg

625023

"State Institution of Health of the Tyumen region Regional Clinical Hospital #1", Tyumen

629001

"State Institution of Health Salekhard District Hospital", Salekhard

630047

"State Institution of Health of Novosibirsk Region City Clinical Hospital #1", Novosibirsk

630117

"Federal State Institution Research Institute of Clinical and Experimental Lymphology", Novosibirsk

644111

"Budget Health Care Institution of Omsk Region Regional Hospital", Omsk

650002

Russian Academy Of Medical Sciences. Reserch Institute For Complex Problems Of Cardiovascular Diseases, Kemerovo

650066

"State Institution of Health of Kemerovo Region Kemerovo Regional Hospital", Kemerovo

656038

"Clinical Hospital Station Barnaul Joint Stock Company Russian Railways , Non-governmental Health Care Institution", Barnaul

660062

"Municipal Budget Health Institution City Clinical Hospital of Emergency Medical Care Named after N.C Karpovich ", Krasnoyarsk

664046

"Autonomous Healthcare Institution Irkutsk Clinical Hospital #1 ", Irkutsk

664079

"State Institution of Health Irkutsk Badge of Honor Regional Hospital", Irkutsk

670031

"State Budgetary Healthcare Institution Republican Clinical Hospital Named after N.A Semashko ", Ulan-Ude

672038

"State Health Care Institution Regional Clinical Hospital", Chita

675028

"State Institution of Health Amur Region Amur Regional Clinical Hospital", Blagoveshchensk

680009

"Regional State Budget Institution of Additional Professional Education Institute of Institute for Advanced Studies of Health Professionals of the Ministry of Health of the Khabarovsk Region", Khabarovsk

690091

"Public Health Institution Primorsky Regional Clinical Hospital #1,", Vladivostok

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Artgen Biotech

OTHER

NCT02369809 - Non-Interventional Post Marketing Surveillance Study of Neovasculgen® in Patients With Chronic Lower Limb Ischemia | Biotech Hunter | Biotech Hunter